Predictive value of serum bone sialoprotein in patients with bone metastasis of non-small cell lung cancer

Onkologie

Volumn 34, Issue 11, 2011, Pages 584-588

  He, Jian Jun ^a   Zhi, Ke ^a   Liu, Guo Feng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bone metastasis; Bone sialoprotein; Non small cell lung cancer; Prognosis

Indexed keywords

BONE SIALOPROTEIN;

ARTICLE; BONE METASTASIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCORTICOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC;

BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; LUNG NEOPLASMS; MIDDLE AGED; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 81855184555     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000334058     Document Type: Article

References (10)

1. Fisher LW, Jain A, Tayback M, Fedarko NS: Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 2004;10:8501-8511. (Pubitemid 40053416)
2. Fisher LW, McBride OW, Termine JD, Young MF Human bone sialoprotein. Deduced protein sequence and chromosomal localization. J Biol Chem 1990;265:2347-2351.
3. Ruoslahti E: RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715. (Pubitemid 26422728)
4. Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T, Chen J: Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Int J Oncol 2003;23:1043-1048.
5. Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, et al.: Predictive significance of bone sialoprotein and osteo-pontin for bone metastases in resected Chinese non-small cell lung cancer patients: a large cohort retrospective study. Lung Cancer 2010;67:114-119.
6. Papotti M, Kalebic T, Volante M, Chiusa L, Bacillo E, Cappia S, Lausi P, Novello S, Borasio P, Scagliotti GV: Bone sialoprotein is predictive of bone metastases in resectable non-small cell lung cancer: a retrospective case-control study. J Clin Oncol 2006;24:4818-4824. (Pubitemid 46630907)
7. Bellahcene A, Maloujahmoum N, Fisher LW, Pastorino H, Tagliabue E, Menard S, Castronovo V: Expression of bone sialoprotein in human lung cancer. Calcif Tissue Int 1997;61:183-188. (Pubitemid 27360809)
8. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW: Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001;7:4060-4066. (Pubitemid 34044628)
9. Bellahcene A, Van Riet I, de Greef C, Antoine N, Young MF, Van Camp B, Castronovo V: Bone sialoprotein mRNA and protein expression in human multiple myeloma cell lines and patients. Br J Haematol 2000;111:1118-1121. (Pubitemid 32104927)
10. Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, et al.: Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 1999;5:3914-3919. (Pubitemid 30013765)